Carmen M. Stanca

Carmen M. Stanca

Transplant Surgery | Hepatology | Gastroenterology

4708 Alliance Blvd Pavilion I,
Ste 240
Plano, TX 75093

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.

Journal: Journal of hepatology

Published: July 27, 2021

Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.

Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.

Journal: The American journal of gastroenterology

Published: December 29, 2020

The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients.

The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients.

Journal: Clinical transplantation

Published: December 07, 2015

Showing 1-3 of 3

Last Updated: 09/26/2026